Lanean...
Sequential and combination treatments with novel agents in chronic lymphocytic leukemia
Chemoimmunotherapy has been the standard of care for patients with chronic lymphocytic leukemia for a long time. However, over the last few years, novel agents have produced unprecedented outcomes in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia. With the advent of these targe...
Gorde:
| Argitaratua izan da: | Haematologica |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Ferrata Storti Foundation
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6821614/ https://ncbi.nlm.nih.gov/pubmed/31585959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.208603 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|